Insider · CIK 0001645627

Mann Michael Scott

CIK 0001645627 Name as filed on the most recent filing

Filed as Mann Michael Scott (241)

4,323 transaction lines · from 241 filings · filed 2015-08-25 to 2019-04-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

4,323 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2019-03-29 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 85, acquired Open Form 4 filing 0001645627-19-000010
2019-03-22 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 4 lines 372, acquired Open Form 4 filing 0001645627-19-000009
2019-03-15 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 42, acquired Open Form 4 filing 0001645627-19-000008
2019-03-15 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 42, acquired Open Form 4 filing 0001645627-19-000009
2019-03-12 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 5 lines 501, acquired Open Form 4 filing 0001645627-19-000007
2019-03-06 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 2 lines 213, acquired Open Form 4 filing 0001645627-19-000007
2019-03-01 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 4 lines 214, acquired Open Form 4 filing 0001645627-19-000007
2019-02-25 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 2 lines 224, acquired Open Form 4 filing 0001645627-19-000007
2019-02-04 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 2 lines 103, acquired Open Form 4 filing 0001645627-19-000005
2019-01-18 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 5 lines 276, acquired Open Form 4 filing 0001645627-19-000004
2019-01-15 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 64, acquired Open Form 4 filing 0001645627-19-000003
2019-01-11 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 5 lines 264, acquired Open Form 4 filing 0001645627-19-000003
2019-01-10 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 4 lines 113, acquired Open Form 4 filing 0001645627-19-000003
2019-01-09 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 2, acquired Open Form 4 filing 0001645627-19-000002
2019-01-09 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 2 lines 57, acquired Open Form 4 filing 0001645627-19-000003
2019-01-07 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 2, acquired Open Form 4 filing 0001645627-19-000002
2019-01-04 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 19, acquired Open Form 4 filing 0001645627-19-000002
2019-01-03 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 5 lines 131, acquired Open Form 4 filing 0001645627-19-000002
2019-01-02 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 89, acquired Open Form 4 filing 0001645627-19-000001
2019-01-02 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 38, acquired Open Form 4 filing 0001645627-19-000001
2019-01-02 P, Open-market purchase Endonovo Therapeutics, Inc.ENDV 19, acquired Open Form 4 filing 0001645627-19-000001

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4,323
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Mann Michael Scott, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001645627

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.